Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2018 Jun 1;21(3):411–418. doi: 10.1038/s41391-018-0043-z

Figure 2.

Figure 2

A: ROC curves comparing AR amplification and CTC based overall survival prognostication. No difference between AUCs for AR amp (0.66) and CTC (0.68), p=0.84

B: No difference between AUCs for AR amp + CTC (0.75) vs. CTC alone (0.68), p=0.08